Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson’s disease. The effect of dopaminergic treatment
✍ Scribed by F. Blandini; M. Cosentino; A. Mangiagalli; F. Marino; A. Samuele; E. Rasini; R. Fancellu; C. Tassorelli; C. Pacchetti; E. Martignoni; G. Riboldazzi; D. Calandrella; S. Lecchini; G. Frigo; G. Nappi
- Book ID
- 106206657
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 392 KB
- Volume
- 111
- Category
- Article
- ISSN
- 1435-1463
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract We investigated non‐rapid eye movement (non‐REM) sleep in patients with newly diagnosed Parkinson's disease (PD) who had never previously received dopaminergic medication. There were no significant differences in the conventional sleep parameters between de novo patients with PD and a h
## Abstract Gender differences in dopaminergic related neurodegenerative diseases have hardly been studied until now. It is generally accepted that more men than women suffer from Parkinson's disease. One of the most prevalent symptoms in Parkinson's patients, hyposmia, does not show gender differe